Taran Therapeutics

Taran Therapeutics is a biotechnology company focused on the discovery and development of novel small molecule therapeutics for oncology and infectious diseases. Founded by Dr. Michael Kinch, the company leverages a proprietary platform to identify and target critical pathways in disease progression, with a specific emphasis on broad-spectrum antiviral agents. Taran Therapeutics aims to address significant unmet medical needs by developing therapies that are effective against emerging viral threats and resistant cancer types. The company is currently in the pre-clinical stage, advancing its lead programs through rigorous validation and optimization. Headquartered in St. Louis, Missouri, Taran Therapeutics operates within a robust network of academic and industry collaborators.